Hydrochloric Acid

Hydrochloric Acid

SCHEMBL602920

CC(C)CCCCCCCCCCCCCCCCCNCCCO.Cl

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 known ✓ O95136 2/20 0.31
S1PR4 known ✓ O95977 2/20 0.31
S1PR1 known ✓ P21453 2/20 0.31
S1PR3 known ✓ Q99500 2/20 0.31
LMNA P02545 3/20 0.37
ALDH1A1 P00352 5/20 0.35
HTT P42858 1/20 0.34
ATM Q13315 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4C Q9H3R0 2/20 0.33
TSHR P16473 1/20 0.33
KDM4A O75164 1/20 0.33
PHF8 Q9UPP1 1/20 0.33
KDM2A Q9Y2K7 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
PAOX Q6QHF9 2/20 0.32
UBE2N P61088 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10703373 0.93 LMNA (0.39) LMNAALDH1A1HTTATMNPSR1
Hydrochloric Acid SCHEMBL8619893 0.91 ALDH1A1 (0.41) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL27684888 0.89 ALDH1A1 (0.42) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL7754958 0.89 ALDH1A1 (0.42) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL11474572 0.89 ALDH1A1 (0.42) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL28467631 0.89 ALDH1A1 (0.42) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL11452986 0.89 ALDH1A1 (0.42) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL10606570 0.89 ALDH1A1 (0.42) LMNAALDH1A1KDM4CTSHRKDM4A
Hydrochloric Acid SCHEMBL9494319 0.89 LMNA (0.46) LMNAALDH1A1KDM4CTSHRKDM4A
SCHEMBL11464311 0.86 ALDH1A1 (0.40) LMNAALDH1A1KDM4CTSHRKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 563 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894015-B1 SHAMPOO COMPOSITION COMPRISING SHEET-LIKE MICROCAPSULES PROCTER & GAMBLE (US) 2026-05-20 EP disclosed
EP-4103335-B1 BOTTLE ADAPTED FOR STORING A LIQUID COMPOSITION WITH AN AESTHETIC DESIGN SUSPENDED THEREIN PROCTER & GAMBLE (US) 2026-05-20 EP disclosed
EP-3663384-B1 PARTICULATE LAUNDRY SOFTENING WASH ADDITIVE PROCTER & GAMBLE (US) 2026-05-06 EP disclosed
EP-3727323-B1 CLEAR SHAMPOO COMPOSITION CONTAINING SILICONE POLYMERS PROCTER & GAMBLE (US) 2026-04-29 EP disclosed
EP-4729046-A2 COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS The Procter & Gamble Company (US) 2026-04-22 EP disclosed
EP-4337333-B1 SHAMPOO COMPOSITION PROCTER & GAMBLE (US) 2026-04-15 EP disclosed
EP-4171483-B1 DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS PROCTER & GAMBLE (US) 2026-04-08 EP disclosed
EP-4349950-B1 FABRIC CARE COMPOSITION PROCTER & GAMBLE (US) 2026-03-25 EP disclosed
US-12576013-B2 Dissolvable solid fibrous shampoo articles containing salts THE PROCTER & GAMBLE COMPANY (US) 2026-03-17 US disclosed
EP-3784352-B1 COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS PROCTER & GAMBLE (US) 2026-03-11 EP disclosed
WO-2006113658-A2 DILUTE FABRIC CARE COMPOSITIONS COMPRISING THICKENERS AND FABRIC CARE COMPOSITIONS FOR USE IN THE PRESENCE OF ANIONIC CARRY-OVER THE PROCTER & GAMBLE COMPANY (US) 2006-10-26 WO disclosed
WO-2006063092-A1 FABRIC ENHANCING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2006-06-15 WO disclosed
US-20060122094-A1 Fabric enhancing composition PROCTER & GAMBLE COMPANY, THE 2006-06-08 US disclosed
WO-2006044875-A1 CONCENTRATED FABRIC SOFTENER ACTIVE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2006-04-27 WO disclosed
US-20060089293-A1 Concentrated fabric softener active compositions PROCTER & GAMBLE COMPANY, THE 2006-04-27 US disclosed
WO-2006014416-A1 PERSONAL CARE COMPOSITIONS CONTAINING CATIONICALLY MODIFIED STARCH AND AN ANIONIC SURFACTANT SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2006-02-09 WO disclosed
US-20060002880-A1 Personal care compositions containing cationically modified starch and an anionic surfactant system THE PROCTER & GAMBLE COMPANY 2006-01-05 US disclosed
EP-1606373-A1 FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH THE PROCTER & GAMBLE COMPANY (US) 2005-12-21 EP disclosed
US-20040204337-A1 Fabric care compositions comprising cationic starch THE PROCTER & GAMBLE COMPANY 2004-10-14 US disclosed
WO-2004087854-A1 FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH THE PROCTER & GAMBLE COMPANY (US) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060002880-A1 Personal care compositions containing cationically modified starch and an anionic surfactant system CUTA, SGMS1, SGMS2 S1PR2 82/4885S1PR4 138/4885S1PR1 61/4885
US-12576013-B2 Dissolvable solid fibrous shampoo articles containing salts SLC6A5, GLUL, SLC6A1 S1PR2 300/4885S1PR4 503/4885S1PR1 362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.